Clear Street, a Wall Street broker, lowers US IPO valuation target to $7.2 billion due to investor caution

Wall Street brokerage firm Clear Street has decided to lower its valuation for its upcoming U.S. initial public offering (IPO) to $7.2 billion, a significant reduction from its initial goal of $11.8 billion. The New York-based company plans to offer 13 million shares priced between $26 and $28 each, compared to the original plan of 23.8 million shares priced between $40 and $44 each.

This adjustment in valuation reflects the current cautious sentiment among investors, despite a recent increase in IPO activity. Investors are prioritizing realistic pricing and showing reservation towards listings that are perceived as overvalued. Market fluctuations have also contributed to subdued valuations, leading companies to approach public offerings with more conservative terms in order to navigate the uncertain market conditions.

In a similar move, Brazilian fintech company Agibank decided to reduce its offering just before its debut, following the underwhelming performance of competitor PicPay in the aftermarket. Additionally, Liftoff Mobile postponed its U.S. listing in response to a sector-wide selloff within the software industry earlier this month.

Reports suggest that Clear Street faced resistance from investors regarding its initial valuation target, which ultimately led to the decision to adjust the pricing expectations. The IPO is scheduled to be priced later on Thursday, with the stock set to trade on the Nasdaq under the symbol “CLRS”.

Clear Street, established in 2018 as a prime brokerage platform, has since expanded its operations to include services in investment banking and equity research. The IPO is being backed by BlackRock, the largest asset manager globally, which has shown interest in purchasing up to $200 million worth of Clear Street shares, according to a filing with the Securities and Exchange Commission. The lead book-running managers for the offering are Goldman Sachs, BofA Securities, Morgan Stanley, UBS Investment Bank, and Clear Street itself.